| Bioactivity | Droloxifene, a Tamoxifen derivative, is an orally active and selective estrogen receptor modulator. Droloxifene shows antiestrogenic and anti-implantation effects. Droloxifene induces p53 expression and apoptosis in MCF-7 cells. Droloxifene prevents bone loss in ovariectomized rats [1][2][3]. | ||||||||||||
| Invitro | Droloxifene (10 nM; 16-18 hours) induces apoptosis in MCF-7 cells[1]. Cell Viability Assay[2] Cell Line: | ||||||||||||
| Name | Droloxifene | ||||||||||||
| CAS | 82413-20-5 | ||||||||||||
| Formula | C26H29NO2 | ||||||||||||
| Molar Mass | 387.51 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
Droloxifene
CAS: 82413-20-5 F: C26H29NO2 W: 387.51
Droloxifene, a Tamoxifen derivative, is an orally active and selective estrogen receptor modulator. Droloxifene shows an
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.